EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of a Patient–Reported Outcome Measure in Parkinson’s Disease

Laurie K Mischley iD, Magdalena Murawska iD

Nutrients · 31.03.2026 · 18 (7) · 1118

DOI: 10.3390/nu18071118 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Nutrients, online erschienen am 31.03.2026. Verfasst von Laurie K Mischley und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute, School of Naturopathic Medicine, Bastyr University, Kenmore, WA 98028, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Patient Reported Outcome Measures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: individuals and families impacted by Parkinson’s disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Patient–Reported Outcomes in Parkinson’s Disease (PRO-PD) scale is a 35-item visual analog measure designed to quantify symptom severity across motor and non-motor domains. Developed as a continuous, patient-centered outcome, PRO-PD captures patient-perceived change over time and is suitable for remote longitudinal assessment. This study evaluated the psychometric properties of PRO-PD across two independent datasets, including reliability, validity, factor structure, and minimal clinically important difference (MCID), and assessed its relevance to nutrition- and lifestyle-focused research.

Methods

Convergent validity was evaluated in a cross-sectional clinical dataset (n = 46) using established clinician-rated and patient–reported instruments, including Hoehn and Yahr, Unified Parkinson’s Disease Rating Scale (UPDRS), Parkinson’s Disease Questionnaire-39 (PDQ-39), Montreal Cognitive Assessment (MoCA), and PROMIS measures. Internal consistency, temporal stability, factor structure, and known-groups validity were assessed in a large remote-monitoring cohort (n = 2612). MCID thresholds were estimated in a longitudinal subsample (n = 390) using anchor-based methods, multinomial regression, and receiver operating characteristic analyses.

Results

PRO-PD demonstrated strong convergent validity with established clinical measures, excellent internal consistency (Cronbach’s α = 0.93 (95% CI: 0.90–0.96) for Small Data and 0.95 (95% CI: 0.947–0.951) for Big Data”), and good test–retest reliability (ICC = 0.78 overall; 0.89 at 6 months). Confirmatory testing of a previously proposed eight-factor structure showed suboptimal fit, leading to a parsimonious four-factor solution (Neurobehavioral, Autonomic, Motor, Mood/Motivation) explaining 47.6% of variance. PRO-PD scores increased significantly with advancing disease duration and stage. MCID thresholds were +53.5 points for worsening and −78.5 points for improvement (AUC = 0.64 for worsened vs. not worsened; AUC = 0.71 for improved vs. worsened), with greater sensitivity for detecting deterioration than improvement. PRO-PD scores demonstrated sensitivity to patient-perceived symptom change over time, supporting its utility for longitudinal monitoring and potential application in lifestyle-focused intervention research.

Conclusions

These findings support PRO-PD as a psychometrically robust outcome measure that can be completed remotely without trained administrators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseasePatient Reported Outcome MeasuresHumansFemaleMaleAgedReproducibility of ResultsMiddle AgedCross-Sectional StudiesPsychometricsSeverity of Illness IndexMinimal Clinically Important DifferenceLongitudinal StudiesSurveys and Questionnaires

Stichwörter der Autor:innen

clinically meaningful changedisease-modificationmeasurement sensitivityneuroprotectionpatient-centered researchpragmatic researchquality of liferating scalesremote patient monitoringscale responsiveness

Autor:innen und Institutionen

  • Research Institute, School of Naturopathic Medicine, Bastyr University, Kenmore, WA 98028, USA.
  • Department of Radiology (Research), School of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Parkinson Center for Pragmatic Research, Seattle, WA 98133, USA.

ORCID-Profile: Laurie K Mischley, Magdalena Murawska

Förderung

  • individuals and families impacted by Parkinson’s disease

Zitieren

APA

Mischley, L. K., & Murawska, M. (2026). Validation of a Patient–Reported Outcome Measure in Parkinson’s Disease. Nutrients, 18(7), 1118. https://doi.org/10.3390/nu18071118

Vancouver

Mischley LK, Murawska M. Validation of a Patient–Reported Outcome Measure in Parkinson’s Disease. Nutrients. 2026;18(7):1118. doi:10.3390/nu18071118

BibTeX
@article{Mischley2026,
  author = {Mischley, Laurie K and Murawska, Magdalena},
  title = {Validation of a Patient–Reported Outcome Measure in Parkinson’s Disease},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {1118},
  doi = {10.3390/nu18071118}
}
Kostenlos starten →